Sema4 Holdings Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Hey, everyone. Good morning. Thanks for joining us today on the third day of our healthcare conference here. I am Tejas Savant, and I cover the life science tools and diagnostic sector at Morgan Stanley. Delighted to have Sema4 join us this morning. And representing the Company, we have Eric Schadt, CEO, and Isaac Ro, CFO. So welcome, gents.
Before we get into the Q&A, just some important disclosures. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep. So Eric, before we get into the weeds on the story, can you just please give us an overview of the genesis of Sema4 and its evolution for those on the webcast not as familiar with the business model.
Sure, Tejas, and thanks for having us today. So Sema4 is a health intelligence company born and raised in the Mount Sinai Health System in New York. We spun out about four and a half years ago and the charter at Mount
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |